Skip to content

03839.HK

Chia Tai Enterprises International Limited

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK

HKD 8.69
−1.03%
Ask drillr
  • Aug 11, 2026, 14:37 UTC

    Zhengda Biotech announced its interim results for the six months ended June 2026, with revenue of $211 million, down 34.6% year-on-year, and net profit of $9.423 million, down 44.7% year-on-year.